Literature DB >> 7543294

Distribution of Tenr, an RNA-binding protein, in a lattice-like network within the spermatid nucleus in the mouse.

J M Schumacher1, K Lee, S Edelhoff, R E Braun.   

Abstract

In a molecular screen for cDNAs that encode protamine RNA-binding proteins, we obtained seven independent clones that encode Tenr, a testis nuclear RNA-binding protein. Tenr is a 72-kDa protein that has one copy of a previously described RNA-binding domain. Northwestern blotting experiments showed that a maltose-binding protein-Tenr fusion binds to a variety of RNAs in vitro and that it does not bind to single-stranded or double-stranded DNA. The Tenr gene is transcribed exclusively in the testis, and its mRNA is restricted to cells from the pachytene spermatocyte stage through the round spermatid stage. Immunolocalization of the Tenr protein within the testis showed that it is first detected postmeiotically, demonstrating that the Tenr mRNA is under translational control. The Tenr protein is localized to round and early elongating spermatid cells, and confocal microscopy revealed a lattice-like nuclear distribution suggesting association with the nuclear scaffold. We suggest that the Tenr protein may be involved in testis-specific nuclear posttranscriptional processes such as heterogeneous nuclear RNA (hnRNA) packaging, alternative splicing, or nuclear/cytoplasmic transport of mRNAs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543294     DOI: 10.1095/biolreprod52.6.1274

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  23 in total

1.  Expression of a nonmyristylated variant of the catalytic subunit of protein kinase A during male germ-cell development.

Authors:  J L Desseyn; K A Burton; G S McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Sequence-independent assembly of spermatid mRNAs into messenger ribonucleoprotein particles.

Authors:  E E Schmidt; E S Hanson; M R Capecchi
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  Two-step binding of transcription factors causes sequential chromatin structural changes at the activated IL-2 promoter.

Authors:  Satoru Ishihara; Ronald H Schwartz
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

4.  Mechanism of interferon action: functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase.

Authors:  Y Liu; C E Samuel
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  A testis cytoplasmic RNA-binding protein that has the properties of a translational repressor.

Authors:  K Lee; M A Fajardo; R E Braun
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

6.  Tad1p, a yeast tRNA-specific adenosine deaminase, is related to the mammalian pre-mRNA editing enzymes ADAR1 and ADAR2.

Authors:  A Gerber; H Grosjean; T Melcher; W Keller
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

Review 7.  Rheumatoid arthritis: a view of the current genetic landscape.

Authors:  M J H Coenen; P K Gregersen
Journal:  Genes Immun       Date:  2008-11-06       Impact factor: 2.676

8.  Effect of mismatch on binding of ADAR2/GluR-2 pre-mRNA complex.

Authors:  Junru Yang; Jianing Song; John Z H Zhang; Changge Ji
Journal:  J Mol Model       Date:  2015-08-08       Impact factor: 1.810

9.  Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.

Authors:  Shehnaz K Hussain; Margaret M Madeleine; Lisa G Johnson; Qin Du; Mari Malkki; Hui-Wen Wilkerson; Federico M Farin; Joseph J Carter; Denise A Galloway; Janet R Daling; Effie W Petersdorf; Stephen M Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

Review 10.  A-to-I editing of coding and non-coding RNAs by ADARs.

Authors:  Kazuko Nishikura
Journal:  Nat Rev Mol Cell Biol       Date:  2015-12-09       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.